ArticleClinics in shoulder and elbow2025
Rationale and methodology for injection therapy to treat rotator cuff disease: a scoping review.
Article in Clinics in shoulder and elbow, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Current management of impingement syndrome and repairable rotator cuff tears in South Korea: A web-based survey.Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology · 2026Article
- Cytoprotective Effects of Lipid Emulsion Against Bupivacaine-Induced Cytotoxicity in Human Rotator Cuff Fibroblasts.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rotator cuff disease is a prevalent musculoskeletal condition associated with significant pain and functional impairment. Various injection therapies, ranging from corticosteroids to advanced biologic approaches, offer potential solutions for managing rotator cuff disease. This scoping review consolidates evidence on the efficacy, safety, and mechanisms of these treatments. Corticosteroid injections, while effective for short-term pain relief, pose risks of tendon degeneration with prolonged use. Platelet-rich plasma demonstrates promise in promoting tendon healing and improving long-term outcomes, but variability in preparation methods limits its clinical consistency. Hyaluronic acid and prolotherapy show potential in improving pain and tendon function, often serving as adjuncts in combined therapeutic strategies. Emerging regenerative options, such as polydeoxyribonucleotide and bone marrow aspirate concentrate, leverage growth factors and stem cells to enhance tendon repair and reduce degeneration, with preliminary evidence supporting their clinical efficacy. By synthesizing current knowledge on injection therapy for rotator cuff disease, this review provides valuable insights for clinicians and researchers seeking to enhance the management of rotator cuff disease through injection therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.